Alaska Stat. § 17.20.085

Current through Chapter 61 of the 2024 Legislative Session and 2024 Executive Orders 125, 133 through 135
Section 17.20.085 - [Effective 11/28/2024] [Effective Until 1/1/2027] Opioid overdose drugs
(a) Notwithstanding a provision or rule of law to the contrary, a health care provider authorized to prescribe an opioid overdose drug may prescribe an opioid overdose drug directly or by standing order or protocol to a person at risk of experiencing an opioid overdose or to a family member, friend, caregiver, or other person in a position to administer an opioid overdose drug to a person at risk of experiencing an opioid overdose.
(b) An employee or volunteer of an opioid overdose program, if acting under a standing order or protocol under (a) of this section, notwithstanding a provision or rule of law to the contrary, may receive a supply of opioid overdose drugs, possess opioid overdose drugs, and provide an opioid overdose drug to a person at risk of experiencing an opioid overdose or to a family member, friend, caregiver, or other person in a position to administer an opioid overdose drug to a person at risk of experiencing an opioid overdose.
(c) The chief medical officer of the department may issue a standing order, including a statewide standing order, for the prescription of an opioid overdose drug.
(d) Annually, on or before October 1, the department shall complete a report describing activities and expenditures related to Substance Abuse and Mental Health Services Administration grants and opioid overdose drug distribution and shall submit the report to the senate secretary and chief clerk of the house of representatives and notify the legislature that the report is available.
(e) In this section,
(1) "health care provider" means a licensed physician, osteopath, dentist, advanced nurse practitioner, physician assistant, nurse, village health aide, or pharmacist operating within the scope of the health care provider's authority;
(2) "opioid" includes the opium and opiate substances and opium and opiate derivatives listed in AS 11.71.140;
(3) "opioid overdose drug" means a drug that reverses, in whole or in part, the pharmacological effects of an opioid overdose;
(4) "opioid overdose program" means a program that provides opioid overdose drugs to persons at risk of experiencing an opioid overdose or to a family member, friend, or other person in a position to assist a person at risk of experiencing an opioid overdose.
(5) "school district" has the meaning given in AS 14.30.145(d).
(f) Notwithstanding a provision or rule of law to the contrary, a school district, if acting under a standing order or protocol under (a) or (c) of this section, may receive a supply of opioid overdose drugs from the department and may possess opioid overdose drugs for the purposes of AS 14.30.145.
(g) Notwithstanding a provision or rule of law to the contrary, a person, if acting under a standing order or protocol under (a) or (c) of this section, may administer an opioid overdose drug under AS 14.30.145 to a person at risk of experiencing an opioid overdose.

AS 17.20.085

Amended by SLA 2024, ch. 47,sec. 3, eff. 11/28/2024.
Amended by SLA 2024, ch. 47,sec. 2, eff. 11/28/2024.
Amended by SLA 2021, ch. 14,§§sec.1, sec.2, sec.3 eff. 6/29/2021.
Amended by SLA 2017, ch. 1,sec. 2, eff. 6/30/2021.
Amended by SLA 2017, ch. 1,sec. 1, eff. 3/21/2017.
Added by SLA 2016, ch. 2,sec. 6, eff. 3/14/2016.
See SLA 2017, ch. 1, sec. 3.
This section is set out more than once due to postponed, multiple, or conflicting amendments.